Key Details
- Read by: Del Hargis delivers Rasmussen's personal account with a grounded warmth that suits the memoir's balance of candor and careful investigation.
- At its heart: Patient agency in cancer treatment, unconventional research and self-advocacy, the human experience of diagnosis and decision-making
- Vibe: Reflective and quietly urgent, with humor appearing at precisely the right moments to make the vulnerability bearable
- Short version: A compact, honest memoir about one man's research into fenbendazole and ivermectin after a prostate cancer diagnosis, best approached as a personal account rather than medical guidance.
Roger Rasmussen did not set out to write a guide when he began researching fenbendazole after his 2019 prostate cancer diagnosis. Finding Fenbendazole is what he produced instead: a memoir that sits in the uncomfortable space between personal urgency and careful skepticism, navigating a subject that has generated both passionate personal accounts and significant medical controversy. This audiobook, narrated by Del Hargis across just under four hours, is honest about what it is and what it is not, and that clarity makes it more trustworthy than the genre of unconventional cancer treatment stories often manages to be.
An Appendix One Reviewer Calls Impressively Thorough
Rasmussen starts with Joe Tippens' story, the widely circulated personal account that brought fenbendazole to the attention of many cancer patients in the late 2010s, and then does something more careful than simply amplifying that account. He reads the available research, which is sparse and preliminary in places, speaks with others on similar paths, and examines his own skepticism alongside his hope. The result is a book that holds both of those things simultaneously rather than resolving them into a simple narrative of discovery or dismissal.
One reviewer describes the book as raw, unfiltered, and grounded in both skepticism and hope, which is an accurate summary of the tonal achievement. Another describes it as the absolute best book on fenbendazole currently available, praising not just the personal story but Rasmussen's descriptions of fenbendazole's mechanisms of action and his review of the existing literature. The appendix with research studies on fenbendazole and ivermectin is described by at least one medically knowledgeable reviewer as impressively thorough, suggesting the investigative work behind the memoir is more rigorous than the casual reader might expect from a personal account of this kind.
The ivermectin thread, which Rasmussen describes as an obvious companion in the conversation, emerges from the same landscape of antiparasitic compounds attracting attention from patients seeking alternatives or supplements to conventional treatment. Rasmussen does not claim curative results for himself or others. He documents a research process and the human questions that drove it, including conversations with others navigating similar situations, and examines the questions that do not appear on medical forms. The subtitle, My Unexpected Path Through Cancer, is the accurate framing: this is a personal account of a research detour, not a protocol.
Hargis Calibrates Between Precision and Vulnerability
Del Hargis is a thoughtful narrator for this material. Rasmussen's prose carries both intellectual precision and personal vulnerability, and Hargis calibrates between those registers without losing the humanity of either. The humor that appears at the right moments, which several reviewers flag as a genuine strength of Rasmussen's writing, lands naturally in the audio format rather than feeling labored. That humor matters: a book about cancer treatment research that stays entirely earnest risks becoming too heavy to absorb, and Rasmussen's self-awareness about the strangeness of his situation, researching compounds found in pet supply aisles, is part of what makes the book honest rather than merely urgent.
At three and a half hours, this audiobook is short enough to complete in a single listening session, which is appropriate: the book is personal and concentrated rather than encyclopedic. The compact format serves the memoir's character, giving it the feeling of a conversation rather than a comprehensive medical survey. Listeners who want more depth on the research side will find the appendix a starting point for further reading rather than the book's main offering.
Neither a Miracle Nor Something to Dismiss
The book is not a medical guide and says so explicitly throughout. Rasmussen is a patient who researched his own situation, not a clinician reviewing evidence for others to act on. The research he describes is preliminary, some of it from case reports rather than randomized clinical trials, and the mechanisms of action he discusses are areas of active investigation rather than established medicine. Listeners facing cancer diagnoses should treat this book as a personal account that opens questions rather than one that answers them, and should engage their oncologist before making any treatment decisions based on what they hear here.
The book also reflects a specific moment in the public conversation about antiparasitic compounds and cancer, a conversation that was shaped significantly by Joe Tippens' viral account and that has continued to evolve in medical and patient communities since Rasmussen's diagnosis in 2019. Listeners should situate the research context accordingly rather than treating the book as a current survey of the field.
What distinguishes Rasmussen's account from many in this space is his refusal to simplify. He does not present fenbendazole as a miracle and he does not dismiss it. He presents it as what it is at the time of his writing: a compound with intriguing case reports, a growing community of people using it, and a mechanism of action that has attracted genuine scientific interest alongside significant skepticism. The intellectual honesty of that position, which requires resisting the pull toward either enthusiastic advocacy or dismissive caution, is what makes the book feel trustworthy.
Fully Realized as a Human Guide
People who have received a cancer diagnosis and are researching unconventional or complementary approaches alongside conventional treatment will find this one of the more carefully written and honest accounts in this space. Caregivers supporting someone with cancer who want to understand why antiparasitic compounds have attracted patient interest will also find Rasmussen's investigation valuable as context. Multiple reviewers describe purchasing copies for family members and listening more than once, which speaks to the book's usefulness as a conversation-starter for those navigating cancer diagnoses.
Those looking for clinical evidence, a treatment protocol, or a curative success story will not find that here. The book's value is in its intellectual honesty and human texture, in what it means to be a patient who researches his own situation with as much rigor as he can muster while living with genuine uncertainty. Rasmussen intended it to be a human guide, not a medical one, and that intention is fully realized.
Questions Listeners Ask
At under four hours, does this audiobook cover the research in enough depth to be useful?
Rasmussen covers fenbendazole's mechanisms of action, ivermectin's emerging interest, conversations with others on similar paths, and a research appendix that medically knowledgeable reviewers describe as impressively thorough. The depth is real within a deliberately compact format.
Who is the intended audience for the Finding Fenbendazole audiobook?
Primarily people with cancer, especially prostate cancer, who are researching options beyond or alongside conventional treatment, and their caregivers. Listeners interested in patient agency, unconventional research, and honest accounts of navigating serious illness will also find the book rewarding.
